Gufic Biosciences · NSE: GUFICBIO · BSE: 509079
Q4 FY19 results · Jan–Mar 2019
Gufic Biosciences reported revenue from operations of ₹91.55 crore and net profit of ₹6.01 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 91.55 | — | — | 87.65 | +4.4% |
| Other income | 3.29 | — | — | 0.23 | 15x |
| Total income | 94.83 | — | — | 87.88 | +7.9% |
| Profit before tax | 10.75 | — | — | 8.79 | +22.3% |
| Net profit for the period | 6.01 | — | — | 5.88 | +2.3% |
| EPS, basic (₹) | 0.77 | — | — | 0.76 | +1.3% |
| Net margin (%) | 6.6 | — | 6.7 |
Standalone
- Filed with BSE
- 12 Jun 2019, 11:31 IST
- Board meeting
- 30 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE